Marlborough-based Sepracor Inc. has hired Philadelphia law firm Drinker Biddle & Reath as a lobbyist on anti-drug compounding legislation.
Drinker Biddle registered Sepracor as a client Aug. 8. Lobbyists are required by the Lobbying Disclosure Act of 1995 to file client registration forms with the U.S. Congress’ Office of Public Records.
Sepracor makes sleep drug Lunesta, among others. Drug compounding is the practice of pharmacists who customize drugs for clients.
